Navigation Links
QuatRx Pharmaceuticals Announces Positive Phase 3 Results for Study of Ophena(TM) (ospemifene) to Treat Postmenopausal Vaginal Syndrome
Date:1/3/2008

lacebo over a 12-week treatment period in women with moderate to severe symptoms of vulvar and vaginal atrophy associated with menopause. A total of 826 women were enrolled in the study.

The primary endpoints for the Phase 3 Ophena(TM) clinical trial were defined as the change from baseline to week 12 in the percentage of parabasal cells in the vaginal maturation index, the percentage of superficial cells in the vaginal maturation index, vaginal pH, and the most bothersome moderate to severe vulvovaginal atrophy symptom, consistent with the appropriate FDA guidance. Top-line data indicate that the study achieved a statistically significant result in each of these co-primary endpoints and that Ophena(TM) was well tolerated.

The study investigated two doses of Ophena(TM) versus placebo, administered once daily, with patients randomized (1:1:1) into a double-blind 12-week treatment period with a four-week follow-up or the opportunity to continue in a long-term safety extension study. All subjects were supplied with a non-hormonal vaginal lubricant to be applied as needed during the 12- week treatment period.

Rochelle Hanley, M.D., chief medical officer of QuatRx Pharmaceuticals, added, "Based on this study, we believe Ophena(TM) is the first drug to demonstrate efficacy in this population over and above the use of topical lubricants. These are important new data that underscore the clinical benefit Ophena(TM) could provide for this common chronic condition."

The full data set from the study is currently being analyzed and will be submitted for presentation at an upcoming scientific meeting and for publication in an appropriate peer-reviewed setting.

About Postmenopausal Vaginal Syndrome

Postmenopausal vaginal syndrome (PVS) is a chronic condition characterized by symptoms including vaginal dryness, sexual pain (dyspareunia), and irritation. Declining estrogen levels during menopause can cause tissues of the vaginal lining to gr
'/>"/>

SOURCE QuatRx Pharmaceuticals Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. QuatRx Completes Patient Enrollment in Phase 3 Study of Ophena(TM) in Women with Postmenopausal Vaginal Syndrome
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
6. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
7. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
8. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
9. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
10. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
11. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... und TÜBINGEN, Deutschland, 5. März 2015 /PRNewswire/ ... und das deutsche biopharmazeutische Unternehmen CureVac geben ... Euro (52 Millionen US-Dollar) in CureVac investiert. ... medizinisch angewandten Messenger-RNA (mRNA). Auf Basis dieses ... Behandlung von Krankheiten und zum Schutz vor ...
(Date:3/5/2015)... , March 5, 2015 Bayer HealthCare announced ... the Conquer Cancer Foundation of the American Society of ... health information technology platform designed to unlock vast quantities ... cancer.  "Bayer is proud to join ... to leverage Big Data to help people whose lives ...
(Date:3/5/2015)...  Medical Diagnostic Laboratories, L.L.C., (MDL), a CLIA-certified, ... automated DNA-based molecular analyses, announces that it is ... utilizes cutting edge technology, including next- generation DNA ... women are diagnosed with cervical cancer in ... Papillomaviruses (HPV) are a group of more than ...
Breaking Medicine Technology:Bill & Melinda Gates Stiftung investiert in CureVac zur Entwicklung innovativer Impfstoffe 2Bill & Melinda Gates Stiftung investiert in CureVac zur Entwicklung innovativer Impfstoffe 3Bill & Melinda Gates Stiftung investiert in CureVac zur Entwicklung innovativer Impfstoffe 4Bayer HealthCare Contributes $1 Million to Support Cancer Care Technology Platform 2Bayer HealthCare Contributes $1 Million to Support Cancer Care Technology Platform 3Medical Diagnostic Laboratories, L.L.C., the Institute for Biomarker Research Announces New HPV Tests 2Medical Diagnostic Laboratories, L.L.C., the Institute for Biomarker Research Announces New HPV Tests 3
... and LOS ANGELES , July 21 /PRNewswire-Asia/ ... or,the "Company"), one of the leading health products distribution and ... of seven new chain,drugstores in July. These new openings ... City, 31 in Baishan City, and a total of ...
... CHARLOTTE, N.C. , July 21 /PRNewswire-FirstCall / -- ... has completed the acquisition of the Anhydro business, a Soeborg, ... and dewatering plants and equipment.  The terms of the transaction were ... , ...
Cached Medicine Technology:China Yongxin Pharmaceuticals Inc. Announces the Expansion of Its Chain of Retail Stores to 110 Stores 2China Yongxin Pharmaceuticals Inc. Announces the Expansion of Its Chain of Retail Stores to 110 Stores 3China Yongxin Pharmaceuticals Inc. Announces the Expansion of Its Chain of Retail Stores to 110 Stores 4SPX Completes Acquisition of Anhydro 2SPX Completes Acquisition of Anhydro 3
(Date:3/5/2015)... AxoGen, Inc. (NASDAQ: AXGN) , a ... repair market, reported record revenue of $4.79 million for ... $2.98 million in the year-ago fourth quarter demonstrating the ... “Our strong fourth quarter revenue growth reflects the market’s ... is driving increased surgeon adoption of our unique product ...
(Date:3/5/2015)... HomeCEUConnection.com is proud to support ... on their nutrition CEUs. To raise awareness ... HomeCEUConnection.com is offering 10% off selected nutrition ... NUTRITION2015 . , High Quality Continuing Education ... high-quality continuing education courses for Physical Therapists, ...
(Date:3/5/2015)... TCS Healthcare Technologies (TCS), a leading ... health management arena, is pleased to announce a webinar ... Advanced Care™ (ACUITY) version 7.20. The session will focus ... advantages of automation. , The webinar, scheduled for March ... by Jeff Frater, RN, BSN, Director of Partner Development ...
(Date:3/5/2015)... Portland, Ore. (PRWEB) March 05, 2015 ... health sciences university founded in 1904, has launched ... behaviors and positive lifestyle changes. The Northwest Center ... educate health professionals, support community outreach, and conduct ... promotion, functional medicine, diet and nutrition. The center ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 INTEGRATED ... healthcare organizations to participate in its 2015 Children’s ... from executive and director-level positions, and the survey ... Last year’s report featured data on 60 executive ... children’s healthcare organizations and 7 subsidiary children’s hospitals. ...
Breaking Medicine News(10 mins):Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 2Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 3Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 4Health News:HomeCEUConnection.com Offers Nutrition CEUs this March to Celebrate Nutrition Month 2Health News:Complimentary Webinar to Explore Enhanced Version of Premier Case Management Software 2Health News:Complimentary Webinar to Explore Enhanced Version of Premier Case Management Software 3Health News:University of Western States Launches Northwest Center for Lifestyle and Functional Medicine 2Health News:Participation Is Now Open For INTEGRATED Healthcare Strategies 2015 Children’s Hospitals Executive Compensation Survey 2
... Reinberg HealthDay Reporter , TUESDAY, Nov. 30 (HealthDay News) ... more vitamin D, a new report from the Institute of Medicine ... day. The IOM did bump up the recommended dietary ... report, released 13 years ago. , , For many people, 600 ...
... (HealthDay News) -- Early assessment of rheumatoid arthritis can ... likelihood of disease remission without having to take disease-modifying ... Although DMARDs are considered effective in treating rheumatoid arthritis, ... linked to uncommon but serious side effects. The ...
... By Amanda Gardner HealthDay Reporter , TUESDAY, ... model, researchers say they,ve determined that relying on "active ... a "reasonable approach" and alternative to immediate treatment, which ... impotence. If the tumor were to start growing ...
... American Society of Hematology (ASH) recognizes the following abstract ... in Orlando, FL, with the highest scoring abstracts in ... resident physician, and post-doctoral fellow. Merit Award winners receive ... The 2010 Merit Award recipients are: ...
... In what might be one of the world,s first ... that they have successfully implanted an experimental device in the ... control his ability to swallow. The device, which could offer ... problems, is controlled by pulling on a tiny metal pin ...
... Nov. 30, 2010 The latest episode in the ... Challenges/Chemistry Solutions ," focuses on the discovery that black ... is the staple food for one-third of the world,s ... allergies, asthma and other diseases. In the ...
Cached Medicine News:Health News:Vitamin D Guidelines Edge Upwards, But Most Americans Getting Enough: Report 2Health News:Vitamin D Guidelines Edge Upwards, But Most Americans Getting Enough: Report 3Health News:Vitamin D Guidelines Edge Upwards, But Most Americans Getting Enough: Report 4Health News:Better Outcomes Seen With Early Rheumatoid Arthritis Diagnosis 2Health News:Study Backs 'Active Surveillance' for Low-Risk Prostate Cancer 2Health News:Study Backs 'Active Surveillance' for Low-Risk Prostate Cancer 3Health News:ASH announces 2010 merit award winners 2Health News:UC Davis surgeons test innovative device in patient with swallowing disorder 2Health News:UC Davis surgeons test innovative device in patient with swallowing disorder 3
Ethicon Endo-Surgery provides disposable handheld instruments that provide reliable, precise performance every time. Our handheld instruments come in 5mm and 10mm sizes....
... Enhanced features including aspiration holes and ... laparoscopic procedures requiring precise dissection with ... increased suction demands. ,Flexible design ... and nonretractable electrodes and multiple tip ...
... including aspiration holes and additional electrode ... requiring precise dissection with decreased risk ... demands. ,Flexible design options allow ... electrodes and multiple tip designs. Optimize ...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
Medicine Products: